The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes

AIM: To better understand the marked decrease in serum triglycerides observed with tirzepatide in patients with type 2 diabetes, additional lipoprotein‐related biomarkers were measured post hoc in available samples from the same study. MATERIALS AND METHODS: Patients were randomized to receive once‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Jonathan M., Nikooienejad, Amir, Robins, Deborah A., Roell, William C., Riesmeyer, Jeffrey S., Haupt, Axel, Duffin, Kevin L., Taskinen, Marja‐Riitta, Ruotolo, Giacomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756479/
https://www.ncbi.nlm.nih.gov/pubmed/33462955
http://dx.doi.org/10.1111/dom.14174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756479/
https://www.ncbi.nlm.nih.gov/pubmed/33462955
http://dx.doi.org/10.1111/dom.14174

Ejemplares similares